Abstract
The active principle Odanacatib (MK-0822) is a highly selective and sensitive inhibitor of capetpsin K (CatKI) that, currently, has been positively highlighted in the osseointegration process, due to its anti-resorptive action, which encouraged this project to evaluate the response implant surface bone coated by double acid etching and Odanacatib (MK-0822) in ovariectomized rats. Thus, in…